-
1ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimensby Rodgers, Mary A., Vallari, Ana S., Yamaguchi, Julie, Holzmayer, Vera, Harris, Barbara, Toure-Kane, Coumba, Mboup, Souleymane, Badreddine, Samar, McArthur, Carole, Ndembi, Nicaise, Mbanya, Dora, Kaptue, Lazare, Cloherty, Gavin“…To determine whether HIV diversity impacts the ARCHITECT HIV Combo Ag/Ab (HIV Combo) or RealTime HIV-1 (RT) assays, a set of N = 199 HIV clinical specimens from Cameroon, Senegal, Saudi Arabia, and Thailand were sequenced and tested in both assays. …”
Published 2018
Get full text
Get full text
Get full text
Online Article Text -
2by Boler, Michael, Anderson, Mark, Rodgers, Mary, Parumoottil, Jessica, Olivo, Ana, Harris, Barbara, Stec, Michael, Gosha, Amy, Behun, Dylan, Holzmayer, Vera, Anderson, Abby, Greenholt, Ella, Fortney, Tiffany, Almaraz, Eduardo, Cloherty, Gavin, Landay, Alan, Moy, James“…This study was performed to evaluate Abbott ARCHITECT serologic assays, AdviseDx SARS-CoV-2 IgG II, and SARS-CoV-2 IgG for the detection of spike (S) and nucleocapsid (N) IgG antibody increases in vaccinated healthcare workers infected with Omicron subvariants. …”
Published 2023
Get full text
Get full text
Get full text
Online Article Text -
3by Anderson, Mark, Holzmayer, Vera, Vallari, Ana, Taylor, Russell, Moy, James, Cloherty, Gavin“…Fingerstick plasma collected in Microtainer tubes (n = 109) showed 100% concordant results (R(2)=0.997) with matched patient venous plasma on the ARCHITECT™ SARS-CoV-2 IgG assay. High concordance of assay results (92.9% positive, 100% negative) was also observed for the PANBIO™ SARS-CoV-2 IgG assay compared to the ARCHITECT™ SARS-CoV-2 IgG assay run with matched venous plasma (n = 61). …”
Published 2021
Get full text
Get full text
Get full text
Online Article Text -
4“…The results demonstrated that the prototype ARCHITECT assay is more sensitive in detecting HBsAg in the presence of anti-HBs than current HBsAg assays. …”
Get full text
Get full text
Get full text
Online Article Text -
5by Holzmayer, Vera, Taylor, Russell, Kuhns, Mary C., Gawel, Susan H., Ndembi, Nicaise, Mbanya, Dora, Kaptue, Lazare, Rodgers, Mary A., Cloherty, Gavin“…We evaluated the use of DBS whole blood samples in the modified Abbott ARCHITECT anti-HCV assay, comparing assay performance against the standard assay run using DBS and venous plasma samples. 144 HCV positive and 104 HCV negative matched venous plasma and whole blood specimens were selected from a retrospective study with convenience sampling in Cameroon. …”
Published 2022
Get full text
Get full text
Get full text
Online Article Text -
6Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohortby Rodgers, Mary A., Holzmayer, Vera, Vallari, Ana, Olivo, Ana, Forberg, Kenn, Fuhrman, Jill, Coller, Kelly E., Awazi, Bih, Kenmegne Sidje, Jules Bertrand, Frankel, Matthew B., Berg, Michael G., Mbanya, Dora, Ndembi, Nicaise, Cloherty, Gavin A.“…All specimens were screened for HCV using the Abbott RealTime HCV viral load assay and positive specimens with remaining volume were also screened for HPgV‐2 antibodies on the Abbott ARCHITECT instrument, followed by molecular characterization. …”
Published 2018
Get full text
Get full text
Get full text
Online Article Text -
7by Bazinet, Michel, Pântea, Victor, Cebotarescu, Valentin, Cojuhari, Lilia, Jimbei, Pavlina, Anderson, Mark, Gersch, Jeff, Holzmayer, Vera, Elsner, Carina, Krawczyk, Adalbert, Kuhns, Mary C., Cloherty, Gavin, Dittmer, Ulf, Vaillant, Andrew“…Supplemental analysis included high‐sensitivity HBsAg (Abbott ARCHITECT HBsAg NEXT), HBV pregenomic RNA (pgRNA), HBsAg/hepatitis B surface antibody (anti‐HBs) immune complexes (HBsAg ICs), and hepatitis B core‐related antigen (HBcrAg). …”
Published 2020
Get full text
Get full text
Get full text
Online Article Text -
8by Bazinet, Michel, Anderson, Mark, Pântea, Victor, Placinta, Gheorghe, Moscalu, Iurie, Cebotarescu, Valentin, Cojuhari, Lilia, Jimbei, Pavlina, Iarovoi, Liviu, Smesnoi, Valentina, Musteata, Tatina, Jucov, Alina, Dittmer, Ulf, Gersch, Jeff, Holzmayer, Vera, Kuhns, Mary, Cloherty, Gavin, Vaillant, Andrew“…Archived serum from the REP 401 study was analyzed using the Abbott ARCHITECT HBsAg NEXT assay (Chicago, IL), Abbott research use–only assays for HBsAg immune complexes (HBsAg ICs), circulating HBV RNA, and the Fujirebio assay for hepatitis B core‐related antigen (HBcrAg; Malvern, PA). …”
Published 2021
Get full text
Get full text
Get full text
Online Article Text -
9by Kuhns, Mary C., Holzmayer, Vera, Anderson, Mark, McNamara, Anne L., Sauleda, Silvia, Mbanya, Dora, Duong, Pham T., Dung, Nguyen T. T., Cloherty, Gavin A.“…Methods: A total of 347 samples collected from the USA, South Africa, Spain, Cameroon, Vietnam, and Cote D’Ivoire representing NAT yield (HBsAg(−), antibody to HBV core antigen (anti-HBc)(−), HBV DNA(+), N = 131), OBI (HBsAg(−), anti-HBc(+), HBV DNA(+), N = 188), and HSLD (HBsAg(+), anti-HBc(+), HBV DNA(+), N = 28) were tested with ARCHITECT HBsAg NEXT (HBsAgNx) (sensitivity 0.005 IU/mL). …”
Published 2021
Get full text
Get full text
Get full text
Online Article Text -
10by Kuhns, Mary C., Holzmayer, Vera, McNamara, Anne L., Anderson, Mark, Cloherty, Gavin A.“…Testing included quantitative hepatitis B surface antigen (HBsAg), antibodies to HBV antigens, quantitative HBV e antigen (HBeAg), HBV DNA, quantitative HBV core-related antigen (HBcrAg), the highly sensitive ARCHITECT HBsAg NEXT (HBsAgNx) assay, and a quantitative research assay for HBV pregenomic RNA (pg RNA). …”
Published 2021
Get full text
Get full text
Get full text
Online Article Text
